Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers [Phase 1]
Nuvectis Pharma reports a Phase 1 clinical trial of NXP-900 in subjects with advanced cancers is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors [EARLY_Phase 1]
Phase I clinical trial update for HLX37 evaluating safety, tolerability, and pharmacokinetics in advanced/metastatic solid tumors. The study…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Prospective Data Collection Initiative on Thoracic Malignancies
A prospective data collection initiative on thoracic malignancies sponsored by the Dutch Society of Physicians for Pulmonology and Tuberculo…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Engagement of Veterans With Lung Cancer [NA]
A clinical trial update indicates the study sponsored by Palo Alto Veterans Institute for Research is currently recruiting veterans with var…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease [Phase 2]
This Phase 2 trial update describes evaluating BIO 300 with thoracic radiation therapy in people with non-small cell lung cancer and interst…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC [Phase 1]
A Phase 1 clinical trial is evaluating intrathecal pemetrexed in combination with bevacizumab for leptomeningeal metastases in non-small cel…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC [Phase 1, Phase 2]
The trial update indicates completion of a Phase 1/2 study evaluating AK112, a PD-1/VEGF bispecific antibody, in patients with non-small cel…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Repositioning Immunotherapy in VetArans With Lung Cancer [Phase 2]
Phase 2 clinical trial update noting recruitment for a repositioned immunotherapy approach in veterans with non-small cell lung cancer. The …
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC [Phase 2]
Phase 2 trial of AK112, a PD1/VEGF bispecific, in combination with chemotherapy for non-small cell lung cancer; currently active but not rec…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial evaluating datopotamab deruxtecan (Dato-DXd) with or without osimertinib vs platinum-based chemotherapy in EGFR-mutat…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping [Phase 2]
Phase 2 trial exploring brigatinib in ALK-positive non-small cell lung cancer with deep phenotyping.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Next Generation Sequencing Method for the Detection of EGFR Gene Mutations in the Plasma of Patients With Lung Cancer [NA]
A clinical trial entry describing a study that evaluates a next-generation sequencing method for detecting EGFR gene mutations in the plasma…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update for HMBD-501 evaluating safety, tolerability, pharmacokinetics, and preliminary efficacy in HER3-e…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup
This clinical trial update describes NCT07441941, evaluating single-fraction pulmonary ablative radiotherapy for oligometastatic lung tumors…
-
EMA approval · 2026-02-27EMA Authorised: Aumseqa (Aumolertinib mesilate) — SFL Pharmaceuticals Deutschland GmbH
The EMA authorised Aumseqa (aumolertinib mesilate) for non-small cell lung cancer, marking EU approval for this EGFR inhibitor with SFL Phar…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study evaluating adverse events and efficacy of Telisotuzumab Adizutecan in combination with a …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease [Phase 2]
A Phase 2 clinical trial is evaluating whether adding stereotactic body radiotherapy to standard of care improves outcomes for patients with…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: 3D Virtual Resection for Predicting Lung Function in VATS
A clinical trial from National Taiwan University Hospital is evaluating 3D virtual resection to predict postoperative lung function after vi…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors [Phase 1]
This clinical trial update describes a Phase 1 study of CGT4255, a selective ERBB2 inhibitor, in adults with ERBB2-altered advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: FDG PET/CT in Lung Cancer Staging [NA]
This ClinicalTrials.gov entry reports the completed status of a study evaluating FDG PET/CT for staging non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of vismodegib and atezolizumab for recurrent or metastatic non-small cell lung cancer; the…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1) [Phase 1]
A multinational Phase 1 trial evaluating the oral EGFR inhibitor DZD6008 in patients with advanced EGFR-mutant Non-Small Cell Lung Cancer, c…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: 18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC [NA]
A completed clinical trial investigates 18F-PD-L1 PET/CT imaging in nivolumab-treated non-small cell lung cancer patients (Stage IV).
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations
An AstraZeneca-sponsored clinical trial update evaluating treatment and biomarker testing patterns and treatment outcomes in non-small cell …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC [Phase 2]
A Phase 2 study investigates induction chemotherapy plus toripalimab followed by chemoradiotherapy for large-volume local advanced non-small…